Obesity-drugmaker Novo Nordisk helps drive Denmark's fastest growth in years

Economic Growth - Denmark's GDP grew by 2.3% in Q3, marking the largest quarter-on-quarter expansion since Q4 2021 [1] - The pharmaceutical industry was the main driver of this growth, with a significant contribution from Novo Nordisk [2] Pharmaceutical Industry Impact - Excluding the pharmaceutical sector, Denmark's economy would have only grown by 0.7% [2] - Novo Nordisk's success with diabetes and weight loss drugs, particularly Ozempic and Wegovy, has significantly influenced Denmark's economic growth [3] Export Performance - Danish exports increased by 4.1% in Q3, with goods exports rising by 4.7% [3] - The growth in goods exports was primarily driven by processed goods and chemicals, linked to the pharmaceutical industry's production growth [4]